<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">MicroPubl Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">MicroPubl Biol</journal-id>
<journal-title-group>
<journal-title>microPublication Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2578-9430</issn>
<publisher>
<publisher-name>Caltech Library</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32550369</article-id>
<article-id pub-id-type="pmc">7255766</article-id>
<article-id pub-id-type="doi">10.17912/micropub.biology.000081</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>New Finding</subject>
</subj-group>
<subj-group subj-group-type="subject">
<subject>Phenotype Data</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A <italic>C. elegans</italic> model for the rare human channelopathy, Timothy syndrome type 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lagoy</surname>
<given-names>Ross</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kim</surname>
<given-names>Heesun</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mello</surname>
<given-names>Craig C.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Albrecht</surname>
<given-names>Dirk R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">§</xref>
</contrib>
<aff id="aff1">
<label>1</label>
Worcester Polytechnic Institute, Department of Biomedical Engineering</aff>
<aff id="aff2">
<label>2</label>
Worcester Polytechnic Institute, Department of Biology &amp; Biotechnology</aff>
<aff id="aff3">
<label>3</label>
University of Massachusetts Medical School, Program in Molecular Medicine</aff>
<aff id="aff4">
<label>4</label>
RNA Therapeutics Institute</aff>
<aff id="aff5">
<label>5</label>
Howard Hughes Medical Institute</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="reviewer">
<name>
<surname>Lee</surname>
<given-names>Raymond</given-names>
</name>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>§</label>
Correspondence to: Dirk R. Albrecht (<email>dalbrecht@wpi.edu</email>)</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="electronic">
<day>18</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date date-type="collection" publication-format="electronic">
<year>2018</year>
</pub-date>
<volume>2018</volume>
<elocation-id>10.17912/micropub.biology.000081</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2018 by the authors</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<funding-group>
<award-group>
<funding-source>NSF</funding-source>
<award-id>CBET1605679</award-id>
</award-group>
<award-group>
<funding-source>NSF</funding-source>
<award-id>EF1724026</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<fig id="f1" orientation="portrait" position="anchor">
<label>Figure 1</label>
<caption>
<p><bold>A human Timothy syndrome mutation in the <italic>C. elegans</italic> voltage-gated calcium channel ortholog <italic>egl-19</italic> by CRISPR-Cas9 HR causes a developmental arrest phenotype.</bold>
<bold>a.</bold> A schematic of the human TS type 1 gain-of-function missense mutation (G406R) in the <italic>C. elegans</italic> ortholog EGL-19 (G369R). <bold>b.</bold> CRISPR-Cas9 HR mix was injected into 55 young adult <italic>C. elegans</italic>. Of 210 F1 roller progeny, 3 were heterozygous for the desired point mutation detected by a PCR/XbaI screen. <bold>c.</bold> Sequence alignment result from a HR positive heterozygous adult animal with the TS mutation. PAM sequence is underlined and small-guide RNA is beneath the arrow. Raw sequence trace result below shows the heterozygous TS A/G peak at the point mutation site (red arrow). <bold>d.</bold>
<italic>C. elegans</italic> developmental arrest phenotype harboring the homozygous TS type 1 human mutation. <bold>e.</bold> Proposed model illustrating possible mechanisms underlying the unexpected <italic>C. elegans</italic> phenotype caused by the human TS type 1 mutation, which may result from worm-specific dysfunction in <italic>egl-19</italic> expression, trafficking, or protein function.</p>
</caption>
<graphic xlink:href="25789430-2018-micropub.biology.000081"></graphic>
</fig>
<sec>
<title>Description</title>
<p>Timothy syndrome (TS) type 1 is a rare genetic human disease caused by a gain-of-function (GOF) missense mutation G406R in the L-type voltage-gated calcium channel (VGCC) a1 subunit gene CACNA1C, which results in severe cardiac arrhythmia and autism (Splawski <italic>et al</italic>. 2004). The <italic>C. elegans</italic> ortholog is EGL-19 (<bold>Fig. 1a</bold>), which is expressed in muscle and neurons (Lee <italic>et al.</italic> 1997). GOF mutations in e<italic>gl-19</italic> cause myotonic phenotypes, while reduction-of-function (ROF) mutants are flaccid, variably elongated, and egg-laying defective, and lethal mutations cause <underline>p</underline>aralysis with <underline>a</underline>rrested elongation at the <underline>t</underline>wo-fold stage (Pat) (Lee <italic>et al.</italic> 1997). Additionally, treatment of embryos with nemadipine-A, an antagonist of L-type VGCCs, causes a severe variable abnormal (Vab) phenotype like some ROF hatchlings (Kwok <italic>et al.</italic> 2006). Neural and muscle cells derived from patients with TS type 1 also yield impaired channel inactivation (Yazawa <italic>et al.</italic> 2011; Paşca <italic>et al.</italic> 2011). Therefore, we hypothesized that insertion of the human TS type 1 GOF mutation in the <italic>C. elegans</italic> genome (G369R) by CRISPR-Cas9 homologous recombination (HR) would cause observable changes in calcium dynamics and serve as a new animal disease model of TS to broadly investigate molecular mechanisms <italic>in vivo</italic>.</p>
<p>Instead, introduction of the TS type 1 human GOF mutation in <italic>C. elegans</italic> resulted in homozygous animals that closely resemble the Vab phenotype (<bold>Fig. 1b-d</bold>), similar to ROF mutant hatchlings and wild type embryos treated with the L-type VGCC antagonist nemadipine-A. This phenotype was observed in three independently edited lines, suggesting it resulted from the human TS mutation rather than a cis loss-of-function mutation in <italic>egl-19</italic> generated by the CRISPR-Cas9 editing. Further, heterozygous animals appeared wild type, which is consistent with recessive inheritance of ROF and lethal mutations in <italic>egl-19</italic>. Taken together, this human mutation appears to dysregulate <italic>egl-19</italic> function in <italic>C. elegans</italic> indirectly, such as through expression, trafficking, or channel kinetics at the cell membrane (<bold>Fig. 1e</bold>). Evaluation of gene expression, protein localization, and functional imaging or electrophysiology in this new animal model of TS type 1 are needed to distinguish among these possibilities.</p>
<p>This result demonstrates that CRISPR-Cas9 can be used to generate human VGCC disease mutations in <italic>C. elegans</italic>, although unexpected phenotypes may result from introducing human mutations in these animals. Nonetheless, this new whole organism model of TS type 1 may provide a foundation for investigating molecular mechanisms involved in this severe genetic disease, screening of additional genetic and therapeutic suppressors as potential treatments for translation, and studying other human channelopathies in <italic>C. elegans</italic>.</p>
</sec>
<sec>
<title>Methods</title>
<p>Plasmid-based CRISPR-Cas9 homologous recombination was performed as previously described (Kim <italic>et al</italic>. 2014). First, a protospacer adjacent motif (PAM) was identified closest to the desired mutation site (<bold>Fig. 1c</bold>). Next, custom designed small-guide RNA (sgRNA) oligomers were designed and ordered (IDT) then annealed and ligated into the sgRNA plasmid backbone pRB1017 (Arribere <italic>et al</italic>. 2014). An 80-nucleotide single stranded oligomer (ssOligo) was custom designed and ordered (IDT) to contain the G-to-R missense mutation, which also co-acted as a silent PAM mutation and XbaI restriction site for efficient PCR screening. The final plasmid injection mix contained 50 ng/µL each of Cas9 vector, pRF4::<italic>rol-6(su1006)</italic> vector, sgRNA vector, and ssOligo donor. By standard microinjection technique (Mello <italic>et al</italic>. 1991), a total of 55 wild type animals were injected and 210 F1 animals were cloned then PCR and XbaI screened. This screen yielded three independent heterozygous HR positive lines (~2% efficiency). The G369R allele was maintained by introduction of the DnT1 genetic balancer strain (LGIV), since homozygous TS type 1 animals were unable to produce offspring. This strain (NZ1074) can be requested by contacting D.R.A. at dalbrecht@wpi.edu.</p>
</sec>
</body>
<back>
<ack>
<sec>
<title>Funding</title>
<p>This work is supported by the Burroughs Wellcome Fund, Career Award at the Scientific Interface (D.R.A.), NSF CBET1605679 (D.R.A.) and EF1724026 (D.R.A.), and C.C.M. is a Howard Hughes Medical Institute Investigator.</p>
</sec>
</ack>
<ref-list>
<ref id="R1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arribere</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>BX</given-names>
</name>
<name>
<surname>Artiles</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Hartman</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Fire</surname>
<given-names>AZ</given-names>
</name>
</person-group>
<year>2014</year>
<month>8</month>
<day>26</day>
<article-title>Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans.</article-title>
<source/>Genetics
          <volume>198</volume>
<issue>3</issue>
<issn>0016-6731</issn>
<fpage>837</fpage>
<lpage>846</lpage>
<pub-id pub-id-type="doi">10.1534/genetics.114.169730</pub-id>
<pub-id pub-id-type="pmid">25161212</pub-id>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ishidate</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ghanta</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Seth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Conte D</surname>
<given-names>Jr</given-names>
</name>
<name>
<surname>Shirayama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mello</surname>
<given-names>CC</given-names>
</name>
</person-group>
<year>2014</year>
<month>5</month>
<day>30</day>
<article-title>A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans.</article-title>
<source/>Genetics
          <volume>197</volume>
<issue>4</issue>
<issn>0016-6731</issn>
<fpage>1069</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="doi">10.1534/genetics.114.166389</pub-id>
<pub-id pub-id-type="pmid">24879462</pub-id>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwok</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Ricker</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>McCourt</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<year>2006</year>
<month>5</month>
<day>01</day>
<article-title>A small-molecule screen in C. elegans yields a new calcium channel antagonist.</article-title>
<source/>Nature
          <volume>441</volume>
<issue>7089</issue>
<issn>0028-0836</issn>
<fpage>91</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1038/nature04657</pub-id>
<pub-id pub-id-type="pmid">16672971</pub-id>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Lobel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hengartner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Horvitz</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Avery</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>1997</year>
<month>10</month>
<day>15</day>
<article-title>Mutations in the alpha1 subunit of an L-type voltage-activated Ca2+ channel cause myotonia in Caenorhabditis elegans.</article-title>
<source/>EMBO J
          <volume>16</volume>
<issue>20</issue>
<issn>0261-4189</issn>
<fpage>6066</fpage>
<lpage>6076</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/16.20.6066</pub-id>
<pub-id pub-id-type="pmid">9321386</pub-id>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mello</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Stinchcomb</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ambros</surname>
<given-names>V</given-names>
</name>
</person-group>
<year>1991</year>
<month>12</month>
<day>01</day>
<article-title>Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.</article-title>
<source/>EMBO J
          <volume>10</volume>
<issue>12</issue>
<issn>0261-4189</issn>
<fpage>3959</fpage>
<lpage>3970</lpage>
<pub-id pub-id-type="pmid">1935914</pub-id>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paşca</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paşca</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cord</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Chikahisa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Dolmetsch</surname>
<given-names>RE</given-names>
</name>
</person-group>
<year>2011</year>
<month>11</month>
<day>27</day>
<article-title>Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome.</article-title>
<source/>Nat Med
          <volume>17</volume>
<issue>12</issue>
<issn>1078-8956</issn>
<fpage>1657</fpage>
<lpage>1662</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2576</pub-id>
<pub-id pub-id-type="pmid">22120178</pub-id>
</element-citation>
</ref>
<ref id="R7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Splawski</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Timothy</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Decher</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bloise</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Condouris</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tager-Flusberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Priori</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Sanguinetti</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>MT</given-names>
</name>
</person-group>
<year>2004</year>
<month>10</month>
<day>01</day>
<article-title>Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.</article-title>
<source/>Cell
          <volume>119</volume>
<issue>1</issue>
<issn>0092-8674</issn>
<fpage>19</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2004.09.011</pub-id>
<pub-id pub-id-type="pmid">15454078</pub-id>
</element-citation>
</ref>
<ref id="R8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dolmetsch</surname>
<given-names>RE</given-names>
</name>
</person-group>
<year>2011</year>
<month>2</month>
<day>01</day>
<article-title>Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.</article-title>
<source/>Nature
          <volume>471</volume>
<issue>7337</issue>
<issn>0028-0836</issn>
<fpage>230</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1038/nature09855</pub-id>
<pub-id pub-id-type="pmid">21307850</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>